Xtampza ER – See Related Topics

Often prescribed for the management of severe pain requiring long-term, daily, and around-the-clock treatment with an opioid when other forms of medication have not worked, Xtampza ER is a newer prescription drug on the market. It is an extended-release formulation of oxycodone, making it a drug that is classified as a Class II opioid by the United States Food and Drug Administration (FDA). This classification indicates that, when used exactly as prescribed, Xtampza is considered a safe drug, however there is still a greater risk to the user for abuse and addiction.

What makes Xtampza ER different though is that it is considered an “abuse-deterrent” opioid. Collegium, the manufacturer of Xtampza ER, formulated the drug so that crushing the capsules will not result in a compromise of the drugs extended-release properties. If somebody attempts to use the drug for recreational purposes, the capsule, once crushed as is typically done for ingestion by inhalation or injection, there will be no sudden onset of oxycodone into the user’s system.

However, as with any opioid-based drug, there is still the chance that a user will consume more of the drug or take it more frequently than is prescribed. This usually happens as a tolerance to the prescribed amount occurs, making it feel like the drug has become less effective. If the user changes the dose, the body can become more dependent on it, and with dependence comes an addiction.

Xtampza ER can become addictive if not used as recommended. Whether you just want to learn more about this prescription drug or suspect someone you know may be dependent on it, The Recovery Village has answers. Check out our related topics or call our hotline to speak with a specialist who can help.

Xtampza ER Related Topics

Mixing Xtampza ER and AlcoholXtampza ER should never be mixed with alcohol because both substances depress the activity of the central nervous system. The combined use of these drugs can lead to liver complications and potentially life-threatening respiratory depression.